Publicaciones en las que colabora con Luis Antón Aparicio (22)

2012

  1. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer

    International Journal of Molecular Sciences, Vol. 13, Núm. 4, pp. 4367-4387

  2. Squamous cell carcinoma ontogeny: Part I

    Squamous Cell Carcinoma (Nova Science Publishers, Inc.), pp. 1-36

  3. Squamous cell carcinoma ontogeny: Part II

    Squamous Cell Carcinoma (Nova Science Publishers, Inc.), pp. 37-68

2011

  1. Tissue array analysis for the differentiation of gliosis from gliomas

    Molecular Medicine Reports, Vol. 4, Núm. 3, pp. 451-457

2010

  1. Evaluation of COX-2, EGFR, and p53 as biomarkers of non-dysplastic oral leukoplakias

    Experimental and Molecular Pathology, Vol. 89, Núm. 2, pp. 197-203

  2. Evaluation of Plakophilin-3 mRNA as a biomarker for detection of circulating tumor cells in gastrointestinal cancer patients

    Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 6, pp. 1432-1440

2009

  1. Diagnostic accuracy of small breast epithelial mucin mRNA as a marker for bone marrow micrometastasis in breast cancer: A pilot study

    Journal of Cancer Research and Clinical Oncology, Vol. 135, Núm. 9, pp. 1185-1195

  2. El papel de los microARNs en el cáncer: desarrollo y potencialidad terapeútica

    Editorial Médica Panamericana

  3. Expression of Wnt gene family and frizzled receptors in head and neck squamous cell carcinomas

    Virchows Archiv, Vol. 455, Núm. 1, pp. 67-75

  4. La ciclooxigenasa-2 (COX-2) y el factor de crecimiento epidérmico (EFG) en lesiones epiteliales orales premalignas

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 31, Núm. 3, pp. 170-181

  5. MicroRNAs as circulating tumor cells biomarkers in gastrointestinal cancer

    EJC SUPPLEMENTS

  6. Prostate stem cells and cell differentiation

    Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 211-241

  7. The role of COX-2 in prostate carcinoma: Therapeutical implications

    Handbook of Prostate Cancer Cell Research: Growth, Signalling, and Survival (Nova Science Publishers, Inc.), pp. 363-388

2008

  1. Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer

    Cancer Detection and Prevention, Vol. 32, Núm. 3, pp. 236-250

  2. Diagnosis value of EGFR gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

  3. Effectiveness of COX2 inhibitor treatment in patients with dysplastic oral leukoplakia

    EJC SUPPLEMENTS

  4. In silico and in vitro analysis of small breast epithelial mucin as a marker for bone marrow micrometastasis in breast cancer

    Advances in Experimental Medicine and Biology

  5. Origin of renal cell carcinomas

    Clinical and Translational Oncology, Vol. 10, Núm. 11, pp. 697-712

  6. Utility of p53 gene expression for early diagnosis in oral leukoplakias

    EJC SUPPLEMENTS

2007

  1. Cyclooxygenase-2 (COX-2): A molecular target in prostate cancer

    Clinical and Translational Oncology, Vol. 9, Núm. 11, pp. 694-702